Figures index

From

Silymarin ameliorates Metabolic Risk Factors and Protects against Cardiac Apoptosis in Streptozotocin-induced Diabetic Rats

Monera A Alabdan

Biomedicine and Biotechnology. 2015, 3(2), 20-27 doi:10.12691/bb-3-2-1
  • Figure 1. Effect of silymarin on body weight in different animal groups at the end of the experimental period. *P < 0.05 with respect to control group. #P < 0.05 with respect to diabetic group
  • Figure 2. Effect of silymarin on the serum level of glucose (mg/dl), insulin (pg.ml), blood HBA1c % and HOMA-IR % of experimental groups. All values are expressed as mean ±SD. Each group consists of six albino rats. *P < 0.05 with respect to control group. # P < 0.05 with respect to diabetic group
  • Figure 3. Flow cytometry analysis of rat cardiomyocytes showing the percentage of apoptosis in different animal groups. Flow cytograms showing examples of data generated by FAC on top of each histogram. *P < 0.05 with respect to control group. # P < 0.05 with respect to diabetic group
  • Figure 4. Flow cytometry analysis of rat cardiomyocytes showing the percentage of Bcl-2 and Bax in different animal groups. Flow cytograms showing examples of data generated by FAC at the side of each histogram. *P < 0.05 with respect to control group. # P < 0.05 with respect to diabetic group
  • Figure 5. Flow cytometry analysis of rat cardiomyocytes showing the percentage of caspases 3and 9 in different animal groups. Flow cytograms showing examples of data generated by FAC at the side of each histogram. *P < 0.05 with respect to control group. # P < 0.05 with respect to diabetic group